Whipplewood Advisors LLC Makes New Investment in Astera Labs, Inc. (NASDAQ:ALAB)

Whipplewood Advisors LLC acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 495 shares of the company’s stock, valued at approximately $66,000.

Other hedge funds have also recently bought and sold shares of the company. Hollencrest Capital Management acquired a new stake in Astera Labs during the third quarter worth approximately $26,000. Kestra Investment Management LLC acquired a new stake in Astera Labs during the fourth quarter worth approximately $28,000. Geneos Wealth Management Inc. acquired a new stake in Astera Labs during the fourth quarter worth approximately $36,000. Global Retirement Partners LLC lifted its position in Astera Labs by 3,155.6% during the fourth quarter. Global Retirement Partners LLC now owns 293 shares of the company’s stock worth $39,000 after acquiring an additional 284 shares during the last quarter. Finally, ORG Wealth Partners LLC bought a new position in shares of Astera Labs during the fourth quarter worth approximately $42,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

ALAB has been the topic of several recent research reports. Craig Hallum raised their target price on shares of Astera Labs from $105.00 to $125.00 and gave the stock a “buy” rating in a report on Tuesday, February 11th. Stifel Nicolaus raised their target price on shares of Astera Labs from $100.00 to $150.00 and gave the stock a “buy” rating in a report on Monday, January 6th. Northland Securities raised shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $120.00 target price on the stock in a report on Tuesday, January 28th. Deutsche Bank Aktiengesellschaft raised their target price on shares of Astera Labs from $60.00 to $100.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. Finally, Northland Capmk raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 28th. One equities research analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $115.33.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $74.35 on Friday. Astera Labs, Inc. has a 1 year low of $36.22 and a 1 year high of $147.39. The stock has a market capitalization of $12.06 billion and a price-to-earnings ratio of -42.98. The company’s 50 day simple moving average is $111.87 and its 200 day simple moving average is $86.19.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Monday, February 10th. The company reported $0.10 earnings per share for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.16). Astera Labs had a negative net margin of 21.05% and a negative return on equity of 10.40%. As a group, analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other news, General Counsel Philip Mazzara sold 7,536 shares of Astera Labs stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $92.07, for a total transaction of $693,839.52. Following the transaction, the general counsel now owns 241,209 shares in the company, valued at approximately $22,208,112.63. The trade was a 3.03 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Manuel Alba sold 63,000 shares of Astera Labs stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $102.94, for a total transaction of $6,485,220.00. Following the transaction, the director now owns 471,863 shares in the company, valued at approximately $48,573,577.22. This trade represents a 11.78 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 827,990 shares of company stock worth $77,096,842 over the last quarter.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.